BRAIN Biotech AG (LON:0RFI)

BRAIN Biotech AG Ratios and Metrics

Market cap in millions GBP. Fiscal year is October - September.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 11, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Market Capitalization	57	39	80	85	189	128
Market Cap Growth	-1.71%	-52.03%	-5.24%	-55.24%	47.93%	-33.23%
Enterprise Value	48	29	77	73	183	111
Last Close Price	2.66	1.63	3.90	3.88	8.46	7.48
PS Ratio	1.24	0.84	1.65	1.92	5.63	3.61
PB Ratio	10.78	3.34	4.03	2.81	5.28	5.39
P/TBV Ratio	10.78	-	14.13	7.48	8.74	18.77
EV/Sales Ratio	1.01	0.62	1.58	1.65	5.44	3.13
Debt / Equity Ratio	-	1.89	0.45	0.31	0.27	0.50
Asset Turnover	0.73	0.70	0.76	0.65	0.52	0.56
Inventory Turnover	-	2.60	2.66	2.72	2.49	2.33
Quick Ratio	0.84	1.41	0.87	0.93	2.78	2.05
Current Ratio	2.39	1.83	1.46	1.42	3.45	2.68
Return on Equity (ROE)	-98.79%	-60.16%	-28.34%	-16.67%	-13.77%	-38.94%
Return on Assets (ROA)	-7.18%	-7.06%	-4.67%	-5.12%	-6.16%	-6.13%
Return on Capital (ROIC)	-44.37%	-15.30%	-8.86%	-8.12%	-9.99%	-12.69%
Return on Capital Employed (ROCE)	-14.10%	-14.10%	-10.40%	-11.30%	-11.10%	-11.30%
Earnings Yield	-17.58%	-24.02%	-8.94%	-6.84%	-2.25%	-6.87%
FCF Yield	-13.91%	-11.09%	-7.38%	-7.56%	-2.34%	-5.38%
Buyback Yield / Dilution	-	-	-	-9.55%	-6.89%	-3.33%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.